Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Although hard numbers on how many people are using compounded versions of brand-name medications are notoriously difficult to find, Menon told me that pharmaceutical companies believe the market for these copycat drugs is fairly significant in size. Some of the really big telehealth companies have partnered directly with pharmaceutical companies to get branded versions of the drugs, Menon said
Clinica Chimica Acta 412, 797801 (2011)
For example, the number of people without any commercial insurance coverage for Zepbound increased by over 14% in 2025
The obesity market is shifting from innovation to access, and Lilly just strengthened its moat.
This triple agonist design differentiates Retatrutide from earlier investigational peptides that primarily targeted one or two metabolic pathways, allowing researchers to explore coordinated endocrine signaling within a single experimental model
inadequate storesespecially in menstruating individualscan worsen shedding
